For the first time, researchers have identified a protein that represses the activity of energy-burning brown fat. The ...

Obesity, diabetes and cardiovascular diseases are increasingly present in the population. Brown adipose tissue has a ...

Scientists have unlocked new details on important receptor proteins—promising targets for the creation of novel drugs for ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Obesity, diabetes and cardiovascular diseases are increasingly present in the population. Brown adipose tissue has a ...

Phase 2a data on Skye Bioscience's (NASDAQ:SKYE) cannabinoid-1 receptor blocker (CB1) for obesity, nimacimab, should be ...

Low-dose colchicine therapy may not alter pericoronary adipose tissue attenuation but can help in improving plaque stability ...

Measuring coronary inflammation with CT imaging improves long-term risk assessment following percutaneous coronary ...

The trial will initially involve healthy obese people receiving single and multiple escalating doses of the therapy.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-ALK7, the company’s investigational RNA interference (RNAi) ...

Associations of road traffic noise with adipose tissue depots and hepatic health – Results from the NAKO study. 2025 Environment International. Volume 201 ...